Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
OPERATING ACTIVITIES
Net income	$ 32,388	$ 38,871
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	10,759	11,531
Provision for credit losses	26,797	10,206
Net amortization of investment securities and assets	4,214	4,676
Net amortization on borrowings	38	38
Stock-based compensation expense	5,290	4,413
Loss on sale of closed branches	17	0
(Gain) loss on sale of foreclosed assets and other real estate owned	(87)	5
Gain on sale of mortgage loans held for sale	(2,007)	(1,864)
Loss on sale of loans	22	0
Deferred income taxes	(1,087)	379
Income from bank owned life insurance	(4,099)	(4,165)
Originations of mortgage loans held for sale	(58,355)	(60,656)
Proceeds from sale of mortgage loans held for sale	63,428	59,994
Changes in assets and liabilities:
Interest receivable	5,845	(351)
Other assets	(16,913)	(17,362)
Accrued interest and other liabilities	(27,856)	17,390
Income taxes payable	(5,598)	(5,511)
Net cash provided by operating activities	32,796	57,594
INVESTING ACTIVITIES
Net change in loans	(106,515)	(163,909)
Proceeds from sale of loans	8,578	211
Proceeds from sale of closed branches	11,077	0
Purchases of premises and equipment, net	(10,151)	(9,848)
Proceeds from sale of foreclosed assets and other real estate owned	1,591	1,218
Proceeds from maturities of available-for-sale securities	74,517	114,212
Purchases of available-for-sale securities	(7,796)	0
Proceeds from maturities of held-to-maturity securities	19,112	17,037
Purchases of bank owned life insurance	(27)	0
Proceeds from bank owned life insurance death benefits	607	1,376
Net cash used in investing activities	(9,007)	(39,703)
FINANCING ACTIVITIES
Net change in deposits	(201,130)	108,026
Proceeds from issuance of other borrowed funds	865,000	575,000
Repayments of other borrowed funds	(725,509)	(675,492)
Dividends paid on common stock	(26,759)	(26,337)
Net change in federal funds purchased and securities sold under agreements to repurchase	13,024	(9,209)
Net shares cancelled under stock compensation plans	(2,342)	(1,638)
Shares issued under employee stock purchase plan	836	970
Net cash used in financing activities	(76,880)	(28,680)
DECREASE IN CASH AND CASH EQUIVALENTS	(53,091)	(10,789)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	687,377	614,092
CASH AND CASH EQUIVALENTS, END OF PERIOD	$ 634,286	$ 603,303